This is the authors' abstract. We don't add key points for this paper.
Background: Emerging evidence indicates that the lymphocyte-albumin (LA) score, a novel biomarker that reflects systemic inflammation and nutritional status, has a strong connection with survival outcomes in a range of tumors; though its prognostic relevance in nasopharyngeal carcinoma (NPC) has not been extensively studied. The aim of this study is to explore the relationship between the LA score and survival outcomes in NPC and to establish a predictive model accordingly. Methods: This single-center retrospective study included 861 non-metastatic NPC patients who were treated with concurrent chemoradiotherapy (CCRT) between January 2010 and December 2014.Clinicopathological data, including the LA score, were collected for analysis. The optimal cutoff value for the LA score was calculated using maximally selected rank statistics. Both univariate and multivariate Cox regression analyses were conducted to identify independent prognostic factors. Additionally, a nomogram incorporating the LA score and other significant variables was developed to predict overall survival (OS). Results: Patients with elevated LA scores (>70.56) demonstrated significantly improved OS compared to those with lower scores (≤70.56) (HR = 0.572, 95% CI: 0.424-0.771, P<0.001). The multivariate analysis revealed that the LA score, along with age, T stage, N stage, and BMI, served as independent prognostic factors for OS. During a median follow-up of 123.2 months, 174 deaths were recorded. The nomogram incorporating these variables demonstrated moderate discriminative ability (C-index = 0.671, 95% CI: 0.631-0.710) and showed modest improvement over the conventional TNM staging system. Conclusion: This study is the first to highlight the prognostic relevance of the LA score in NPC patients undergoing CCRT. The LA score, being a straightforward and readily available biomarker, can complement anatomical staging for better risk stratification and personalized treatment strategies in this challenging malignancy.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ni et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: